Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel

Shmuel Stienlauf; Vered Yahalom; Eli Schwartz; Eilat Shinar; Gad Segal; Yechezkel Sidi

doi:10.3201/eid1507.080796

Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel

Shmuel Stienlauf^*
, Vered Yahalom
, Eli Schwartz
, Eilat Shinar
, Gad Segal
, Yechezkel Sidi

^*Corresponding author for this work

Sheba Medical Center at Tel Hashomer
Magen David Adom

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

Original language	English
Pages (from-to)	1116-1118
Number of pages	3
Journal	Emerging Infectious Diseases
Volume	15
Issue number	7
DOIs	https://doi.org/10.3201/eid1507.080796
State	Published - Jul 2009

Access to Document

10.3201/eid1507.080796

Cite this

@article{6dbd541da6ed4f0b9b31d54c398fa98a,

title = "Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel",

abstract = "The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.",

author = "Shmuel Stienlauf and Vered Yahalom and Eli Schwartz and Eilat Shinar and Gad Segal and Yechezkel Sidi",

year = "2009",

month = jul,

doi = "10.3201/eid1507.080796",

language = "אנגלית",

volume = "15",

pages = "1116--1118",

journal = "Emerging Infectious Diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "7",

}

TY - JOUR

T1 - Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel

AU - Stienlauf, Shmuel

AU - Yahalom, Vered

AU - Schwartz, Eli

AU - Shinar, Eilat

AU - Segal, Gad

AU - Sidi, Yechezkel

PY - 2009/7

Y1 - 2009/7

N2 - The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

AB - The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and 20.4, respectively. HTLV-1 prevalence may be high outside areas where HTLV-1 previously was known to be endemic.

UR - https://www.scopus.com/pages/publications/67650648210

U2 - 10.3201/eid1507.080796

DO - 10.3201/eid1507.080796

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 19624934

AN - SCOPUS:67650648210

SN - 1080-6040

VL - 15

SP - 1116

EP - 1118

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

IS - 7

ER -

Epidemiology of human T-cell lymphotropic virus type 1 infection in blood donors, Israel

Abstract

Access to Document

Other files and links

Fingerprint

Cite this